Skip to content

Pharmacokinetic, pharmacodynamic and clinical profile of HIV-1 Reverse Transcriptase inhibitors

HIV-1 Reverse Transcriptase inhibitor

Recent Posts

  • Martinez A, Alcantara S, Borrell V, Delrio JA, Blasi J, Otal R, Campos N, Boronat A, Barbacid M, Silossantiago I, Soriano E
  • A meta-analysis of 4 randomized tests showed non-inferiority of the reduced dose for probably the most composite actions of disease activity and patient-reported outcomes
  • (E) The scatter plot illustrates the relationship between the levels of sera anti-HIV gp140 IgG and the percent of total NK cells, from a common donor, activated by the sera in the whole blood ADCC assay in the presence of gp140
  • Locally produced salusin- may act in adjacent endothelial cells to accelerate inflammatory responses [20] also
  • The recombinant flaviviral VLPs form a more compact particle compared to the virions but maintain similar antigenicity and protect mice against viral infection39C43

Recent Comments

  1. A WordPress Commenter on Hello world!

Acetylcholinesterase

June 20, 2022

(E) The scatter plot illustrates the relationship between the levels of sera anti-HIV gp140 IgG and the percent of total NK cells, from a common donor, activated by the sera in the whole blood ADCC assay in the presence of gp140

(E) The scatter plot illustrates the relationship between the levels of sera anti-HIV gp140 IgG and...

Read More
  • Acetylcholinesterase

Pharmacokinetic, pharmacodynamic and clinical profile of HIV-1 Reverse Transcriptase inhibitors © 2022. All Rights Reserved.

Powered by WordPress. Theme by Alx.